1. Fungal infectionsJohn E Edwards1 and Priya Uppuluri2UCLA David Geffen School of Medicine, USA. 1E-mail: jedwards@labiomed.org, 2E-mail: puppuluri@labiomed.org2. Fungal infections- The South-Asian perspectiveArunaloke ChakrabartiDivision of Mycology, Postgraduate Institute of Medical Education & Research, Chandigarh, India. E-mail: arunaloke@gmail.com3. Regulatory pathways during C. albicans infectionsAaron P. MitchellMellon Institute, Department of Biological Sciences, Carnegie Mellon University, Pittsburgh, USA. E-mail: apm1@andrew.cmu.edu4. Virulence mechanisms and regulationChristophe D'EnfertFungal Biology and Pathogenicity Unit - INRA USC2019, Department of Mycology, Institut Pasteur, Paris, France. E-mail: christophe.denfert@pasteur.fr
5. Signalling mechanisms in pathogenesis and virulence of C. albicans 6. Biofilm development by C. albicansDavid AndesDepartment of Medicine, University of Wisconsin School of Medicine and Public Health, Madison WI, USA. E-mail: dra@medicine.wisc.edu7. Biofilm development and resistance mechanisms by C. albicansPatrick Van Dijck1 and Mary-Ann Jabra Rizk21 VIB Department of Molecular Microbiology, KU Leuven, Kasteelpark, Arenberg, Leuven, Belgium. 2 University of Maryland School of Dentistry, Maryland, USA. 1E-mail: Patrick.VanDijck@mmbio.vib-kuleuven.be, 2E-mail: MRizk@umaryland.edu8. Biofilm of C. albicans: development and regulationAshraf S. Ibrahim1 and Priya Uppuluri29. Host immune responses during infectionsGordon BrownThe Institute of Medical Sciences, University of Aberdeen, Scotland. E-mail: gordon.brown@abdn.ac.uk10. Mechanism of drug resistance Dominique SanglardInstitute of Microbiology, University Hospital Lausanne and University Hospital Center, Lausanne, Switzerland. E-mail: Dominique.Sanglard@chuv.ch11. Structure- function analyses of Multi-drug transportersRichard D. Cannon Department of Oral Sciences, University of Otago, Dunedin, New Zealand. E-mail: richard.cannon@otago.ac.nz12. All about MFS multi-drug transporter of Candida albicansRajendra Prasad1, Peer Abdul Haseeb Shah2 and Archana Redhu21Amity Institute of Integrative Sciences and Health and Amity Institute of Biotechnology, Amity University, Haryana, India. 2Membrane biology Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi, India. 1E-mail: rp47jnu@gmail.com, rprasad@ggn.amity.edu13. Inhibitors/Modulators of MDR transporters Attilio Di PietroInstitute for the Biology and Chemistry of Protein, Lyon, France. E-mail: a.dipietro@ibcp.fr14. Inhibitors/Modulators of MDR proteins/transportersBrian MonkDepartment of Oral Sciences, University of Otago, Dunedin, New Zealand. E-mail: brian.monk@otago.ac.nz15. Anti-fungals
David PerlinPublic Health Research Institute Center, New Jersey Medical School - Rutgers, The State University of New Jersey, New Jersey, USA. E-mail: perlinds@umdnj.edu16. Anti-microbial peptidesJoachim Ernst and Marc SwidergallInstitut für Mikrobiologie, Molekulare M